Couple on the beach at tropical resort Travel concept

FDA Finalizes Rule to Phase Out Enforcement Discretion of Laboratory-Developed Tests

Start
On April 29, the U.S. Food and Drug Administration (FDA) released a final rule that will gradually phase out FDA’s long-standing policy of enforcement discretion for laboratory-developed tests (LDTs), subjecting them to the same enforcement approach as other in vitro diagnostic (IVD) products. FDA had previously issued the proposed rule in September of last year….
By: Manatt, Phelps & Phillips, LLP
Previous Story

FDA Finalizes Rule Regulating Laboratory Developed Tests

Next Story

Understanding State Prescription Drug Affordability Board Landscape in Three Infographics